Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

TRML

Tourmaline Bio (TRML)

Tourmaline Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRML
DateTimeSourceHeadlineSymbolCompany
09/11/20243:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
09/05/20243:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
09/03/20246:45AMGlobeNewswire Inc.Tourmaline Bio to Present at Upcoming Investor ConferencesNASDAQ:TRMLTourmaline Bio Inc
08/22/20243:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
08/20/20245:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
08/08/20247:46AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRMLTourmaline Bio Inc
08/08/20246:44AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
08/08/20246:30AMGlobeNewswire Inc.Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:TRMLTourmaline Bio Inc
08/02/20243:30PMGlobeNewswire Inc.Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024NASDAQ:TRMLTourmaline Bio Inc
06/27/20247:05AMGlobeNewswire Inc.Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial OfficerNASDAQ:TRMLTourmaline Bio Inc
06/07/20243:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
06/07/20243:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
06/07/20243:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
05/23/20246:10AMGlobeNewswire Inc.Tourmaline Bio to Present at the Jefferies Global Healthcare ConferenceNASDAQ:TRMLTourmaline Bio Inc
05/16/20246:00AMGlobeNewswire Inc.Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY TrialNASDAQ:TRMLTourmaline Bio Inc
05/13/20243:18PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRMLTourmaline Bio Inc
05/13/20246:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
05/13/20246:00AMGlobeNewswire Inc.Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:TRMLTourmaline Bio Inc
04/02/20246:00AMGlobeNewswire Inc.Avalo Therapeutics Appoints Biotech Leaders to Board of DirectorsNASDAQ:TRMLTourmaline Bio Inc
03/19/20246:00AMGlobeNewswire Inc.Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:TRMLTourmaline Bio Inc
02/27/20246:30AMGlobeNewswire Inc.Tourmaline Bio to Present at Upcoming Investor ConferencesNASDAQ:TRMLTourmaline Bio Inc
02/14/20248:08PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TRMLTourmaline Bio Inc
02/14/20247:51PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TRMLTourmaline Bio Inc
02/09/20243:22PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TRMLTourmaline Bio Inc
02/01/20247:00AMGlobeNewswire Inc.Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology ConferenceNASDAQ:TRMLTourmaline Bio Inc
01/29/20243:01PMGlobeNewswire Inc.Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:TRMLTourmaline Bio Inc
01/26/20243:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
01/26/20243:08PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRMLTourmaline Bio Inc
01/25/20246:00AMGlobeNewswire Inc.Tourmaline Bio Announces Pricing of Public Offering of Common StockNASDAQ:TRMLTourmaline Bio Inc
01/24/20248:20PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRMLTourmaline Bio Inc
 Showing the most relevant articles for your search:NASDAQ:TRML